Ruilope LM - Search Results

1

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. Among authors: ruilope lm. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.

2

Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.

Ruilope L, Jäger B, Prichard B. Ruilope L, et al. Blood Press. 2001;10(4):223-9. doi: 10.1080/08037050152669747. Blood Press. 2001. PMID: 11800061 Clinical Trial.

3

ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?

Ruilope LM, Segura J, Schiffrin EL. Ruilope LM, et al. J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):74-9. doi: 10.3317/jraas.2003.016. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 12806588 Free article. Review.

4

Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.

Ruilope LM, Segura J. Ruilope LM, et al. Clin Ther. 2003 Dec;25(12):3044-64. doi: 10.1016/s0149-2918(03)90091-9. Clin Ther. 2003. PMID: 14749145 Review.

5

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL. Ruilope LM, et al. J Hypertens. 2004 Jan;22(1):217-22. doi: 10.1097/00004872-200401000-00032. J Hypertens. 2004. PMID: 15106814 Clinical Trial.

6

Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.

Ruilope LM, Rosei EA, Bakris GL, Mancia G, Poulter NR, Taddei S, Unger T, Volpe M, Waeber B, Zannad F. Ruilope LM, et al. Blood Press. 2005;14(4):196-209. doi: 10.1080/08037050500230227. Blood Press. 2005. PMID: 16126553 Review.

7

Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr, Januszewicz A. Haller H, et al. Among authors: ruilope lm. J Hypertens. 2006 Feb;24(2):403-8. doi: 10.1097/01.hjh.0000202820.56201.e6. J Hypertens. 2006. PMID: 16508590 Clinical Trial.

8

Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial.

Bakris GL, Ruilope L, Locatelli F, Ptaszynska A, Pieske B, Raz I, Voors AA, Dechamplain J, Weber MA. Bakris GL, et al. J Hum Hypertens. 2006 Sep;20(9):693-700. doi: 10.1038/sj.jhh.1002050. Epub 2006 May 18. J Hum Hypertens. 2006. PMID: 16710287 Clinical Trial.

9

Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.

Bakris GL, Ruilope LM, McMorn SO, Weston WM, Heise MA, Freed MI, Porter LE. Bakris GL, et al. Among authors: ruilope lm. J Hypertens. 2006 Oct;24(10):2047-55. doi: 10.1097/01.hjh.0000244955.39491.88. J Hypertens. 2006. PMID: 16957566 Clinical Trial.

10

Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.

Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM. Schmieder RE, et al. Among authors: ruilope lm. Diabetes Care. 2007 Jun;30(6):1351-6. doi: 10.2337/dc06-1551. Epub 2007 Mar 2. Diabetes Care. 2007. PMID: 17337492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters